- Release Date: 02/11/23 08:27
- Summary: Preliminary update from ongoing Phase 2 Study of Paxalisib
- Price Sensitive: No
- Download Document 150.76KB
- Forums
- ASX - By Stock
- KZA
- Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib
Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online